KRAS and pancreatic ductal adenocarcinoma: Within the spectrum of pancreatic neoplasms, pancreatic ductal adenocarcinoma (PDAC) constitutes over 90% of all cases, with Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations detected in nearly 9 out of 10 PDAC instances [3,4].